FDA Recall Open, Classified

TruSignal Integrated Ear Sensor with Ohmeda Connector REF TS-E4-H; Oximeter

Recall: Z-2034-2023 · Initiated May 19, 2023

Recall

Recall Number
Z-2034-2023
Event Number
92455
Firm
GE Healthcare Finland Oy Kuortaneenkatu 2 Helsinki Finland
FEI Number
3002806783
Product Code
DPZ
Status
Open, Classified
Root Cause
Device Design
Initiated
May 19, 2023
Posted
July 7, 2023

Description

TruSignal Integrated Ear Sensor with Ohmeda Connector REF TS-E4-H; Oximeter

Reason

There is a potential reduction of energy reaching patient during defibrillation, potential contact with unintended voltage, or inaccurate measurement.

Action

GE Healthcare issued an URGENT MEDICAL DEVICE CORRECTION notice on 05/19/2023. The notice explained the safety issues associated with the us of the device and requested the actions be taken: Actions to be taken by Customer/User for Safety Issue # 1 and #2: 1. Use an alternate method for SpO2 monitoring such as TruSignal Sensors not impacted by this field action, or an alternate SpO2 device, if possible 2. If alternate methods are not possible, the affected TruSignal SpO2 Sensors can be used for monitoring if they have not been saturated with fluids 3. If defibrillation is necessary, when the affected TruSignal SpO2 Sensors are being used, please follow the instructions below: I. Remove the affected TruSignal SpO2 Sensor (see Table 1 below) from the patient II. Defibrillate the patient, per hospital protocol III. Reattach the affected TruSignal SpO2 Sensor after defibrillation is no longer needed Actions to be taken by Customer/User for Safety Issue #3: 1. Before using Adult/Pediatric SpO2 Sensors (see Table 1), confirm that the sensor does not contain additional material covering the emitter or detector. 2. If any additional material is present, discard the sensor and select another sensor.

Distribution

Worldwide

Quantity

237 devices